Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
This study is currently recruiting participants.
Verified June 2012 by Yale University
Sponsor:
Yale University
Collaborator:
Mayo Clinic
Information provided by (Responsible Party):
James Boyer, Yale University
ClinicalTrials.gov Identifier:
NCT01456468
First received: October 14, 2011
Last updated: June 28, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |